JUNEL FE 1.5/30

Post-LOE

norethindrone acetate and ethinyl estradiol and ferrous fumarate

Teva

ANDAORAL-28TABLET

Approved

Sep 2003

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

JUNEL FE 1.5/30 (norethindrone acetate and ethinyl estradiol and ferrous fumarate) by Teva is estrogen receptor agonists [moa]. Approved for pregnancy in women. First approved in 2003.

Drug data last refreshed 18h ago

Mechanism of Action

Estrogen Receptor Agonists

Pharmacologic Class:

Estrogen

Indications (1)

pregnancy in women

Company

Worked on JUNEL FE 1.5/30 at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.